2m 2m 2m 2m 2m 2m 2m
NUVECTIS PHARMA (NVCT)
NASDAQ
$21.02+$0.02 (+0.07%)
Price as of Nov 12, 2026 5:58 AM EST- $722.2MMarket Cap
- 249.42%1-Year Change
- BiotechnologyIndustry
NUVECTIS PHARMA (NVCT)
$21.02+$0.02 (+0.07%)
NVCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.00 | ||
Change | -$0.08 (-0.38%) | ||
Open | $21.31 | ||
High | $21.78 | ||
Low | $20.60 | ||
Previous Close | $21.08 | ||
Volume | 153,124 | ||
30-Day Average Volume | 201,835 | ||
1-Week Change | 13.70% | ||
1-Month Change | -0.57% | ||
1-Year Change | 249.42% | ||
3-Year Change | 160.55% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 34.4M | ||
Total Assets | $140.8M | ||
Market Cap | $722.2M | ||
Enterprise Value | $581.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$30.1M | ||
Free Cash Flow | -$25.3M | ||
EBIT | -$30.1M | ||
EBITDA | -$30.1M | ||
Net Working Capital | $126.6M | ||
EPS | -$1.02 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -21 | ||
PEG | 0 | ||
Price/Free Cash Flow | -29 | ||
Price/Operating Cash Flow | -29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue